Dr. Afshin Safavi is a founder, CEO, councilman, consultant, board member, Scientist, entrepreneur, and investor in biotechnology, pharmaceutical, animal health, technology, and real-estate sectors with multi-billion-dollar turnovers in biological products and is responsible for multiple drug products in the market today. He is the founder of Summit Impact Partners (SIP) and Colorado Health & Tech Centers (CHTC). Prior to that, he founded BioAgilytix Labs, one of the most successful multi-billion-dollar Contract Research Organizations known internationally. He has extensive experience establishing and leading teams in start-ups, as well as Fortune 500 biotech and pharmaceutical companies. He has worked with clients and companies in more than 30 countries. Dr. Safavi obtained his B.S. in Biochemistry from UCLA and his Ph.D. in Biochemistry from the University of Kentucky Medical School. He completed a two-year postdoctoral assignment at Emory University.